ATC Code A02BC05
Formula C17H19N3O3S
Molar Mass (g·mol−1) 345,42
Physical State solid
Melting Point (°C) 155
PKS Value - 4.78
CAS Number 119141-88-7
PUB Number 9568614
Drugbank ID DB00736
Solubility low in water


Esomeprazole is a medication that reduces stomach acid. It belongs to the group of drugs called proton pump inhibitors. It is used to treat gastroesophageal reflux disease, peptic ulcer disease, and Zollinger-Ellison syndrome. It is taken by mouth or as an injection into a vein.



Esomeprazole exerts its effect by preventing the final step of gastric acid production. In doing so, it covalently binds to the enzyme H+/ K+-ATPase on the surface of the gastric islet cells. This effect results in inhibition of gastric acid secretion, regardless of the stimulus. Because the binding of esomeprazole to the enzyme is irreversible and new enzyme must be expressed to resume acid production, the duration of the antisecretory effect of esomeprazole lasts longer than 24 hours.


A single oral dose of 20 to 40 mg generally results in maximum plasma concentration within 1 to 4 hours. The drug is rapidly eliminated from the body, largely by urinary excretion of pharmacologically inactive metabolites such as 5-hydroxymethylesomeprazole and 5-carboxyesomeprazole. The plasma half-life is approximately 1-1.5 hours.

Drug Interactions

Esomeprazole is a competitive inhibitor of the enzyme CYP2C19 and may therefore interact with drugs that are metabolised by this enzyme, these include diazepam and warfarin. The concentrations of these drugs may increase when used concomitantly with esomeprazole.

Furthermore, clopidogrel is a so-called prodrug whose conversion to its active form is partly dependent on CYP2C19. Inhibition of CYP2C19 blocks the activation of clopidogrel and thus reduces its effect.


Side effects

Common side effects are headache, diarrhea, nausea, bloating, decreased appetite, constipation, dry mouth, and abdominal pain.

More serious side effects include severe allergic reactions, chest pain, dark urine, fast heartbeat, fever, paresthesias, persistent sore throat, severe stomach pain, unusual bruising or bleeding, unusual tiredness, and yellowing of the eyes or skin.


  • Drugbank
  • PubChem
  • Aktories, Förstermann, Hofmann, Starke: Allgemeine und spezielle Pharmakologie und Toxikologie, Elsvier, 2017
Markus Falkenstätter

Markus Falkenstätter

Markus Falkenstätter ist Autor zu pharmazeutischen Themen in der Medizin-Redaktion von Medikamio. Er befindet sich im letzten Semester seines Pharmaziestudiums an der Universität Wien und liebt das wissenschaftliche Arbeiten im Bereich der Naturwissenschaften.

Mag. pharm Stefanie Lehenauer

Mag. pharm Stefanie Lehenauer

Stefanie Lehenauer ist seit 2020 freie Autorin bei Medikamio und studierte Pharmazie an der Universität Wien. Sie arbeitet als Apothekerin in Wien und ihre Leidenschaft sind pflanzliche Arzneimittel und deren Wirkung.

Your personal medicine assistent

afgis-Qualitätslogo mit Ablauf Jahr/Monat: Mit einem Klick auf das Logo öffnet sich ein neues Bildschirmfenster mit Informationen über Medikamio GmbH & Co KG und sein/ihr Internet-Angebot: This website is certified by Health On the Net Foundation. Click to verify.

Search our database for drugs, sorted from A-Z with their effects and ingredients.


All substances with their common uses, chemical components and medical products which contain them.


Causes, symptoms and treatment for the most common diseases and injuries.

The contents shown do not replace the original package insert of the medicinal product, especially with regard to dosage and effect of the individual products. We cannot assume any liability for the correctness of the data, as the data was partly converted automatically. A doctor should always be consulted for diagnoses and other health questions. Further information on this topic can be found here.